These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Sustained intraocular VEGF neutralization results in retinal neurodegeneration in the Ins2(Akita) diabetic mouse. Hombrebueno JR; Ali IH; Xu H; Chen M Sci Rep; 2015 Dec; 5():18316. PubMed ID: 26671074 [TBL] [Abstract][Full Text] [Related]
4. Dysregulation of trophic factors contributes to diabetic retinopathy in the Ins2 Araújo RS; Silva MS; Santos DF; Silva GA Exp Eye Res; 2020 May; 194():108027. PubMed ID: 32259534 [TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling. Park SW; Jun HO; Kwon E; Yun JW; Kim JH; Park YJ; Kang BC; Kim JH Vascul Pharmacol; 2017 Mar; 90():19-26. PubMed ID: 27473515 [TBL] [Abstract][Full Text] [Related]
6. Agents that bind annexin A2 suppress ocular neovascularization. Lima e Silva R; Shen J; Gong YY; Seidel CP; Hackett SF; Kesavan K; Jacoby DB; Campochiaro PA J Cell Physiol; 2010 Nov; 225(3):855-64. PubMed ID: 20607799 [TBL] [Abstract][Full Text] [Related]
7. Angiography reveals novel features of the retinal vasculature in healthy and diabetic mice. McLenachan S; Magno AL; Ramos D; Catita J; McMenamin PG; Chen FK; Rakoczy EP; Ruberte J Exp Eye Res; 2015 Sep; 138():6-21. PubMed ID: 26122048 [TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy. Wisniewska-Kruk J; Klaassen I; Vogels IM; Magno AL; Lai CM; Van Noorden CJ; Schlingemann RO; Rakoczy EP Exp Eye Res; 2014 May; 122():123-31. PubMed ID: 24703908 [TBL] [Abstract][Full Text] [Related]
9. Chlorogenic acid attenuates diabetic retinopathy by reducing VEGF expression and inhibiting VEGF-mediated retinal neoangiogenesis. Mei X; Zhou L; Zhang T; Lu B; Sheng Y; Ji L Vascul Pharmacol; 2018 Feb; 101():29-37. PubMed ID: 29146180 [TBL] [Abstract][Full Text] [Related]
10. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor. Yang W; Yu X; Zhang Q; Lu Q; Wang J; Cui W; Zheng Y; Wang X; Luo D Exp Eye Res; 2013 Oct; 115():96-105. PubMed ID: 23810809 [TBL] [Abstract][Full Text] [Related]
11. A novel small molecule ameliorates ocular neovascularisation and synergises with anti-VEGF therapy. Sulaiman RS; Merrigan S; Quigley J; Qi X; Lee B; Boulton ME; Kennedy B; Seo SY; Corson TW Sci Rep; 2016 May; 6():25509. PubMed ID: 27148944 [TBL] [Abstract][Full Text] [Related]
12. Loss-of-function mutation of serine racemase attenuates retinal ganglion cell loss in diabetic mice. Jiang H; Du J; Song J; Li Y; Wu M; Zhou J; Wu S Exp Eye Res; 2018 Oct; 175():90-97. PubMed ID: 29913163 [TBL] [Abstract][Full Text] [Related]
13. Long-term lutein administration attenuates retinal inflammation and functional deficits in early diabetic retinopathy using the Ins2 Wang W; Tam KC; Ng TC; Goit RK; Chan KLS; Lo ACY BMJ Open Diabetes Res Care; 2020 Jul; 8(1):. PubMed ID: 32665315 [TBL] [Abstract][Full Text] [Related]
14. Retinal and Choroidal Changes after Anti Vascular Endothelial Growth Factor Therapy for Neovascular Age-related Macular Degeneration. Kim SW; Woo JE; Yoon YS; Lee S; Woo JM; Min JK Curr Pharm Des; 2019; 25(2):184-189. PubMed ID: 30892159 [TBL] [Abstract][Full Text] [Related]
15. Intravitreal injection of erythropoietin protects against retinal vascular regression at the early stage of diabetic retinopathy in streptozotocin-induced diabetic rats. Mitsuhashi J; Morikawa S; Shimizu K; Ezaki T; Yasuda Y; Hori S Exp Eye Res; 2013 Jan; 106():64-73. PubMed ID: 23178551 [TBL] [Abstract][Full Text] [Related]
16. Differential hypoxic response of human choroidal and retinal endothelial cells proposes tissue heterogeneity of ocular angiogenesis. Mammadzada P; Gudmundsson J; Kvanta A; André H Acta Ophthalmol; 2016 Dec; 94(8):805-814. PubMed ID: 27255568 [TBL] [Abstract][Full Text] [Related]
17. Reduced ocular blood flow as an early indicator of diabetic retinopathy in a mouse model of diabetes. Muir ER; Rentería RC; Duong TQ Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6488-94. PubMed ID: 22915034 [TBL] [Abstract][Full Text] [Related]
18. Influence of endotoxin-mediated retinal inflammation on phenotype of diabetic retinopathy in Ins2 Akita mice. Vagaja NN; Binz N; McLenachan S; Rakoczy EP; McMenamin PG Br J Ophthalmol; 2013 Oct; 97(10):1343-50. PubMed ID: 23913246 [TBL] [Abstract][Full Text] [Related]
19. Anti-angiogenic effect of adiponectin in human primary microvascular and macrovascular endothelial cells. Palanisamy K; Nareshkumar RN; Sivagurunathan S; Raman R; Sulochana KN; Chidambaram S Microvasc Res; 2019 Mar; 122():136-145. PubMed ID: 30144414 [TBL] [Abstract][Full Text] [Related]
20. Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate. Tolentino MJ; McLeod DS; Taomoto M; Otsuji T; Adamis AP; Lutty GA Am J Ophthalmol; 2002 Mar; 133(3):373-85. PubMed ID: 11860975 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]